Rationale: Recently, respiratory syncytial virus (RSV) RNA has been identified by reverse transcriptase-polymerase chain reaction (RT-PCR) from a high percentage of patients with stable chronic obstructive pulmonary disease (COPD). These data raise the possibility of persistent low-grade infection in this population, which could have implications in COPD pathogenesis. Objectives: RSV persistence was investigated by testing respiratory secretions from subjects with COPD during illness and at regular intervals over 1 yr. Methods: Nasal and sputum samples from subjects with COPD were tested by one-tube nested RT-PCR for RSV every 2 mo and during respiratory illnesses for 1 yr. Subjects positive for RSV were evaluated weekly until negative in two consecutive samples. Nasal secretions and serum were tested for RSV antibody. A rise of fourfold or greater was defined as evidence of RSV infection. Results: A total of 112 patients were enrolled and the illnesses of 92 patients were evaluated. RSV was detected by RT-PCR in 6/92 (6.5%) illness nasal samples versus 0/685 routine nasal samples and in 5/69 (7.2%) illness sputum samples versus 3 /315 (0.9%) routine. Four additional RSV infections were identified by serum antibody responses. Of the RSV infections 86% were associated with serum or nasal antibody responses and 73% had symptoms of acute respiratory illness. Conclusions: Most RSV infections in patients with COPD are associated with symptomatic respiratory illnesses and measurable immune responses. Our data do not support the concept of RSV persistence in this population.
Keywords: chronic obstructive pulmonary disease exacerbation; persistent infection; viral infectionChronic obstructive pulmonary disease (COPD) is a group of disorders characterized by airflow obstruction that can be associated with breathing-related symptoms such as chronic cough, dyspnea, and wheezing (1). It is estimated that approximately 24 million adults in the United States have impaired lung function due to COPD. During 2000, COPD was responsible for 8 million physician office visits, 1.5 million emergency room visits, 726,000 hospitalizations, and 119,000 deaths. Recurrent acute exacerbations of COPD contribute substantially to the morbidity and mortality of this condition and may be due to infections with bacteria, viruses, or both (2-4). In studies of COPD exacerbation, respiratory syncytial virus (RSV) has been identified with variable frequency ranging from 0.8 to 22% depending on the diagnostic methods used (5-16). Recently investigators from the United Kingdom and Germany identified RSV RNA by reverse In our laboratory, we have developed a sensitive and specific real-time, one-tube nested RT-PCR for the diagnosis of RSV in adults (19,20). Because the assay is performed without opening the reaction tube, PCR contamination has been markedly reduced while the sensitivity of a nested assay is retained. Therefore, we sought to explore the question of RSV persistence in patients with COPD by testing upper-and lower-respiratorytract secreti...